Syngene International Ltd

Syngene Intl. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Syngene International Ltd

₹ 718 -1.14%
01 Apr 11:39 a.m.
syngeneintl.com BSE: 539268 NSE: SYNGENE
About

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million square feet across locations. [1]

Key Points

Business Footprint:[1]
The company caters to diverse end-user industries like Pharmaceuticals, Animal Health, Agrochemicals, Consumer Packaged Goods, Chemicals/Polymers.
It has 400+ active customers with engagements with 13 out of the top 15 global pharma companies. The company holds 400+ patents jointly with clients and has a base of 6000+ scientists.

Website BSE NSE
  • Market Cap ₹ 28,894 Cr.
  • Current Price ₹ 718
  • High / Low ₹ 961 / 608
  • Stock P/E 62.9
  • Book Value ₹ 107
  • Dividend Yield 0.17 %
  • ROCE 13.4 %
  • ROE 12.0 %
  • Face Value ₹ 10.0
    Edit ratios

    Pros

    • Company has reduced debt.
    • Company is almost debt free.

    Cons

    • Stock is trading at 6.70 times its book value
    • Promoter holding has decreased over last quarter: -1.98%
    • The company has delivered a poor sales growth of 11.9% over past five years.
    • Company has a low return on equity of 13.0% over last 3 years.
    • Dividend payout has been low at 10.5% of profits over last 3 years

    * The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

    Peer comparison

    Sector: Healthcare Industry: Miscellaneous

    Part of BSE 500 BSE SmallCap Nifty LargeMidcap 250 Nifty Midcap 150 Nifty MidSmallcap 400

    Edit Columns
    Loading peers table ...

      Quarterly Results

      Standalone Figures in Rs. Crores / View Consolidated

      Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
      640 759 644 768 787 994 716 831 792 865 726 821 877
      437 509 473 552 556 678 552 614 592 565 578 613 626
      Operating Profit 203 249 172 216 230 316 163 217 200 299 148 209 251
      OPM % 32% 33% 27% 28% 29% 32% 23% 26% 25% 35% 20% 25% 29%
      13 15 16 15 17 23 23 14 25 15 50 16 18
      Interest 9 6 9 12 14 10 6 9 6 8 7 7 7
      Depreciation 78 80 86 90 95 88 89 91 94 96 92 94 92
      Profit before tax 128 178 92 129 139 241 92 131 125 210 99 124 170
      Tax % 19% 17% 20% 21% 21% 21% 18% 22% 20% 10% 25% 22% 28%
      103 147 73 102 110 189 75 102 100 190 74 97 123
      EPS in Rs 2.58 3.67 1.82 2.53 2.73 4.71 1.87 2.53 2.48 4.72 1.84 2.40 3.06
      Raw PDF

      Profit & Loss

      Standalone Figures in Rs. Crores / View Consolidated

      Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
      550 700 860 1,107 1,201 1,423 1,826 2,012 2,179 2,601 3,194 3,203 3,290
      382 485 579 727 816 950 1,290 1,395 1,504 1,861 2,252 2,322 2,383
      Operating Profit 168 214 281 380 385 473 536 617 676 741 942 881 907
      OPM % 31% 31% 33% 34% 32% 33% 29% 31% 31% 28% 29% 28% 28%
      4 8 12 6 94 53 75 153 94 75 63 74 99
      Interest 6 0 8 8 18 23 32 35 28 24 45 30 30
      Depreciation 60 66 81 97 114 131 164 219 274 310 359 369 373
      Profit before tax 106 157 204 281 346 372 414 516 467 482 601 557 603
      Tax % 4% 14% 14% 14% 17% 18% 20% 20% 14% 18% 21% 16%
      102 135 175 241 287 305 331 412 404 394 473 466 483
      EPS in Rs 9.43 12.45 4.38 6.02 7.18 7.63 8.27 10.29 10.09 9.83 11.78 11.60 12.02
      Dividend Payout % 0% 0% 239% 8% 7% 7% 3% 0% 0% 10% 11% 11%
      Compounded Sales Growth
      10 Years: 16%
      5 Years: 12%
      3 Years: 14%
      TTM: -1%
      Compounded Profit Growth
      10 Years: 13%
      5 Years: 7%
      3 Years: 7%
      TTM: -3%
      Stock Price CAGR
      10 Years: %
      5 Years: 24%
      3 Years: 7%
      1 Year: 3%
      Return on Equity
      10 Years: 16%
      5 Years: 14%
      3 Years: 13%
      Last Year: 12%

      Balance Sheet

      Standalone Figures in Rs. Crores / View Consolidated

      Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
      Equity Capital 26 26 199 200 200 200 200 400 400 401 401 402 402
      Reserves 492 633 646 825 1,213 1,520 1,767 1,774 2,418 2,891 3,218 3,790 3,916
      4 155 155 891 806 787 813 773 893 1,022 639 332 364
      201 377 422 440 555 681 922 1,215 1,166 1,247 1,590 1,310 1,068
      Total Liabilities 724 1,191 1,422 2,356 2,775 3,188 3,702 4,162 4,878 5,561 5,848 5,834 5,750
      381 394 503 580 810 1,030 1,377 2,020 2,201 2,393 2,260 2,318 2,318
      CWIP 9 45 105 237 175 155 274 234 237 346 126 760 809
      Investments 69 352 146 277 540 158 716 777 702 1,034 941 928 932
      265 399 667 1,262 1,249 1,845 1,336 1,132 1,737 1,787 2,521 1,829 1,692
      Total Assets 724 1,191 1,422 2,356 2,775 3,188 3,702 4,162 4,878 5,561 5,848 5,834 5,750

      Cash Flows

      Standalone Figures in Rs. Crores / View Consolidated

      Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
      104 300 18 308 398 446 630 677 698 582 838 913
      -150 -375 16 -753 -470 -350 -646 -424 -629 -611 -685 -383
      21 155 -10 716 -81 -79 -72 -226 58 -31 -340 -536
      Net Cash Flow -26 80 24 272 -153 17 -88 28 127 -60 -187 -6

      Ratios

      Standalone Figures in Rs. Crores / View Consolidated

      Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
      Debtor Days 51 49 76 61 60 68 68 72 79 71 55 49
      Inventory Days 45 28 59 44 37 82 30 18 41 87 141 95
      Days Payable 208 146 106 87 116 194 154 157 166 115 110 104
      Cash Conversion Cycle -112 -68 29 18 -19 -44 -56 -67 -45 44 86 41
      Working Capital Days 5 -61 -6 -10 -14 -28 -65 -115 -19 -4 32 -22
      ROCE % 25% 23% 23% 20% 18% 16% 17% 17% 14% 13% 15% 13%

      Shareholding Pattern

      Numbers in percentages

      Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      70.41% 70.29% 64.86% 64.86% 54.88% 54.80% 54.79% 54.79% 54.79% 54.72% 54.72% 52.74%
      13.69% 14.15% 16.79% 16.87% 23.31% 23.19% 23.55% 21.20% 20.92% 20.64% 20.72% 20.65%
      4.41% 4.18% 6.75% 7.03% 10.71% 11.20% 11.70% 14.63% 15.80% 16.78% 17.49% 19.52%
      10.81% 10.56% 11.11% 10.77% 10.65% 10.23% 9.47% 9.07% 8.18% 7.44% 6.74% 6.79%
      0.68% 0.83% 0.49% 0.47% 0.46% 0.60% 0.48% 0.32% 0.31% 0.43% 0.34% 0.29%
      No. of Shareholders 1,33,6101,28,2781,34,3341,27,9641,24,0141,25,4551,25,9921,21,8801,15,8501,20,0181,07,3381,28,806

      * The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

      Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

      Click on the line-items to see the names of individual entities.

      Documents

      Announcements

      Annual reports

      DRHP

      Credit ratings

      Concalls